ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $80,028 | -52.6% | 16,200 | +3.2% | 0.00% | – |
Q3 2022 | $169,000 | -1.2% | 15,700 | -16.4% | 0.00% | – |
Q1 2022 | $171,000 | -54.3% | 18,771 | +31.2% | 0.00% | -100.0% |
Q2 2021 | $374,000 | +36.0% | 14,310 | +83.5% | 0.00% | +100.0% |
Q1 2021 | $275,000 | +12.2% | 7,800 | +20.0% | 0.00% | 0.0% |
Q3 2020 | $245,000 | -31.8% | 6,500 | -22.6% | 0.00% | -50.0% |
Q2 2020 | $359,000 | – | 8,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |